Literature DB >> 6604365

S-sulfonation: a reversible chemical modification of human immunoglobulins permitting intravenous application. I. Physicochemical and binding properties of S-sulfonated and reconstituted IgG.

P Gronski, T Hofstaetter, E J Kanzy, G Lüben, F R Seiler.   

Abstract

S-sulfonation represents a reversible chemical modification of disulfide bonds by which under the special conditions chosen only about 2.2 cystine units per IgG molecule are cleaved. Physicochemical and functional evidence for reconstitution is presented. Molecules reconstituted in vitro or in vivo regain, within a few hours, a reactivity (antigen binding, immunoprecipitation, Clq-mediated cross-linking of immune complexes) comparable to equimolar control preparations.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6604365     DOI: 10.1111/j.1423-0410.1983.tb01899.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  6 in total

Review 1.  New and old aspects of immunoglobulin application. The use of intravenous IgG as prophylaxis and for treatment of infections.

Authors:  L Hammarström; C I Smith
Journal:  Infection       Date:  1990 Sep-Oct       Impact factor: 3.553

2.  Dose-response relationship in the treatment of idiopathic thrombocytopenic purpura with intravenous immunoglobulin.

Authors:  B Emmerich; E Hiller; F Woitinas; P A Maubach; H Riess; C Nerl; R G Geursen
Journal:  Klin Wochenschr       Date:  1987-04-15

3.  Reduced efficacy of sulfitolysed intravenous immunoglobulin.

Authors:  W Stephan; H Dichtelmüller
Journal:  Eur J Clin Microbiol       Date:  1984-02       Impact factor: 3.267

Review 4.  Passage of intravenous immunoglobulin and interaction with the CNS.

Authors:  U Wurster; J Haas
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-11       Impact factor: 10.154

Review 5.  Small molecule generators of biologically reactive sulfur species.

Authors:  Prerona Bora; Preeti Chauhan; Kundansingh A Pardeshi; Harinath Chakrapani
Journal:  RSC Adv       Date:  2018-07-31       Impact factor: 4.036

6.  Treatment of idiopathic West and Lennox-Gastaut syndromes by intravenous administration of human polyvalent immunoglobulins.

Authors:  K van Rijckevorsel-Harmant; M Delire; M Rucquoy-Ponsar
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1986
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.